Literature DB >> 15135343

Preoperative assessment of multicentric occurrence in synchronous small and multiple hepatocellular carcinoma based on image-patterns and histological grading of non-cancerous region.

Shinichi Ueno1, Dai Aoki, Tetsu Maeda, Fumitake Kubo, Hirohumi Hokotate, Yoshihiko Fukukura, Takashi Aikou.   

Abstract

Recent studies have shown that the prognosis of patients with multicentric occurrence (MO) of hepatocellullar carcinoma (HCC) after curative resection, whether synchronous or metachronous, is significantly better than that of patients with intrahepatic metastasis (IM). We attempted to elucidate a group with high probability of MO of HCC by comparing the preoperative ultrasonography (US), computed tomography during arterial portography (CTAP) and CT arteriography (CTA) images with the histological grading of the non-cancerous region of the liver. The imaging and pathological characteristics of 97 nodules in 45 patients diagnosed as having small (<5cm) and oligonodular HCCs preoperatively were investigated. Histological diagnoses were as follows: 18 MO, 23 IM, and 4 unclassified (HCC with benign nodule). Histological grade of the liver tissue was assessed using the hepatitis activity index (HAI) score. No significant differences in tumor location and the mean size of co- or daughter nodules were noticed between the MO and IM patients. Of the 38 nodules in the MO patients, 20 were diagnosed as hyperechoic lesions on US, 20 as negative enhanced lesions on CTA and 12 as having positive portal flow on CTAP. A comparison of image-patterns between the synchronous nodules revealed that the MO group showed different images in at least one imaging technique, whereas in most IM patients similar images were produced by two or three imaging techniques. Moreover, all MO patients had an [Formula: see text], although more than half the IM patients had an [Formula: see text]. In patients with small and oligonodular HCCs, the nodules are highly likely to display MO, when showing both 1 or more different image patterns among US, CTA and CTAP and severe hepatitis such as HAI score >/=8.

Entities:  

Year:  2004        PMID: 15135343     DOI: 10.1016/j.hepres.2004.02.003

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  8 in total

Review 1.  Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma.

Authors:  Tohru Utsunomiya; Mitsuo Shimada; Satoru Imura; Yuji Morine; Tetsuya Ikemoto; Masaki Mori
Journal:  J Gastroenterol       Date:  2009-12-08       Impact factor: 7.527

2.  Clonality analysis for multicentric origin and intrahepatic metastasis in recurrent and primary hepatocellular carcinoma.

Authors:  Qiang Li; Jian Wang; Jonathan T Juzi; Yan Sun; Hong Zheng; Yunlong Cui; Haixin Li; Xishan Hao
Journal:  J Gastrointest Surg       Date:  2008-07-16       Impact factor: 3.452

3.  Tumor grade may be used to select patients with multifocal hepatocellular carcinoma for resection.

Authors:  Samantha M Ruff; Luke D Rothermel; Laurence P Diggs; Michael M Wach; Reed I Ayabe; Sean P Martin; David Boulware; Daniel Anaya; Jeremy L Davis; John E Mullinax; Jonathan M Hernandez
Journal:  HPB (Oxford)       Date:  2019-11-13       Impact factor: 3.647

Review 4.  Identifying Clonal Origin of Multifocal Hepatocellular Carcinoma and Its Clinical Implications.

Authors:  Di-Yang Xie; Hong-Kai Fan; Zheng-Gang Ren; Jia Fan; Qiang Gao
Journal:  Clin Transl Gastroenterol       Date:  2019-02       Impact factor: 4.488

5.  Diagnosis and Resection Treatment of Triplet Hepatocellular Carcinomas with a non-B non-C Background in a Middle Aged Man over a Period of 6-years.

Authors:  Akira Kajiwara; Keiichi Kinowaki; Norio Akuta; Kayoko Kasuya; Nozomu Muraishi; Soichi Iritani; Yusuke Kawamura; Shunichiro Fujiyama; Hitomi Sezaki; Tetsuya Hosaka; Satoshi Saitoh; Masahiro Kobayashi; Mariko Kobayashi; Yasuji Arase; Kenji Ikeda; Fumitaka Suzuki; Hiromitsu Kumada; Yoshiyuki Suzuki
Journal:  Intern Med       Date:  2020-06-23       Impact factor: 1.271

6.  Effectiveness of Particle Radiotherapy in Various Stages of Hepatocellular Carcinoma: A Pilot Study.

Authors:  Yushi Sorin; Kenji Ikeda; Yusuke Kawamura; Shunichiro Fujiyama; Masahiro Kobayashi; Tetsuya Hosaka; Hitomi Sezaki; Norio Akuta; Satoshi Saitoh; Fumitaka Suzuki; Yoshiyuki Suzuki; Yasuji Arase; Hiromitsu Kumada
Journal:  Liver Cancer       Date:  2018-03-14       Impact factor: 11.740

7.  Radiofrequency ablation with the real-time virtual sonography system for treating hepatocellular carcinoma difficult to detect by ultrasonography.

Authors:  Hiroaki Kawasoe; Yuichiro Eguchi; Toshihiko Mizuta; Tsutomu Yasutake; Iwata Ozaki; Tomonori Shimonishi; Kohji Miyazaki; Tsutomu Tamai; Akira Kato; Sho Kudo; Kazuma Fujimoto
Journal:  J Clin Biochem Nutr       Date:  2007-01       Impact factor: 3.114

8.  Clinical Features and Clonal Origin of Diffuse Hepatocellular Carcinoma.

Authors:  Zheng-Lu Wang; Lu-Zhou Zhang; Yu-Liang Wang; Wei-Ping Zheng; Hong Zheng
Journal:  Chin Med J (Engl)       Date:  2018-05-05       Impact factor: 2.628

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.